Renhua Guo

4PUBLICATIONS
3CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 26, 2025
Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop.

Chen Zhang, Wenxin Zhou, Hai Xu

|May 08, 2023
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.

Jiali Dai, Tianyu Qu, Dandan Yin

|May 04, 2022
Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.

Xiyi Lu, Jing Wang, Wei Wang

|Sep 12, 2021
Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer.

Chen Zhang, Honggang Cao, Yanan Cui

Pageof 1

Frequent Collaborators

3 joint publications

Erbao Zhang

1 joint publications

Xiyi Lu

1 joint publications

Wei Wang